Oscar Health (OSCAR) Reports Q4 Losses Up, Revenue Falls

Oscar Health, Inc. (OSCAR) reported a wider fourth-quarter loss on February 11, 2026, with net income down to -$19.9 million, versus -$14.8 million in the same period of 2025. Revenue declined to $1.09 billion, a 3.4% drop from $1.13 billion in Q4 2025. The company cited continued pressure from lower utilization of health benefits and broader economic conditions. The stock closed at $52.30 on February 10, 2026, down 2.8% for the session.